In exclusive written Q&A with Science|Business, EU commissioner for research, innovation, education and youth vows hundreds of millions for coronavirus R&D but calls on member states to agree on the multiannual budget to avoid delaying critical research.
The European Commission’s R&D toolbox in the COVID-19 outbreak includes extended deadlines in Horizon 2020, additional funding opportunities for viral research - and less red tape
EU president Charles Michel says there is ‘strong common will’ between G7 countries to deliver coronavirus vaccine, following reports of big-money overture by president Trump to CureVac
For the innovators behind new biodegradable, recyclable products, the EU’s biggest-ever climate and environment battle plan opens up opportunities for growth
For the innovators behind new biodegradable, recyclable products, the EU’s biggest-ever climate and environment battle plan opens up opportunities for growth
Early stage human trials for vaccine against the virus are ‘days or weeks’ away, but it will take at least 12 – 18 months to complete safety and efficacy tests, and much more money is needed
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.